Effect of the GPI anchor of human Thy-1 on antibody recognition and function

Laboratory Investigation

Volumn 93, Issue 3, 2013, Pages 365-374

  Bradley, John E ^a   Chan, Joy M ^b   Hagood, James S ^c  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

antibody recognition; delipidated Thy 1; fibroblast; GPI anchor; recombinant Thy 1

Indexed keywords

GLYCEROL; GLYCOSYLPHOSPHATIDYLINOSITOL; MONOCLONAL ANTIBODY; THY 1 ANTIGEN;

ANTIBODY AFFINITY; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; BIOASSAY; BIOLOGICAL FUNCTIONS; BODY FLUID; CELL SURFACE; CELL VACUOLE; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DISULFIDE BOND; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; LIGAND BINDING; LUNG FIBROBLAST; MOLECULAR CLONING; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN GLYCOSYLATION; PROTEIN HYDROLYSIS;

EID: 84874590722     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2012.178     Document Type: Article

References (39)

1. Reif AE, Allen JM. Specificity of isoantisera against leukaemic and thymic lymphocytes. Nature 1963;200:1332-1333
2. Reif AE, Allen JM. The AKR thymic antigen and its distribution in leukemias and nervous tissues. J Exp Med 1964;120:413-433
3. Rege TA, Hagood JS. Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB J 2006;20:1045-1054
4. Rege TA, Hagood JS. Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses. Biochim Biophys Acta 2006;1763:991-999
5. Bradley JE, Ramirez G, Hagood JS. Roles and regulation of Thy-1, a context-dependent modulator of cell phenotype. Biofactors 2009;35:258-265
6. Hagood JS, Prabhakaran P, Kumbla P, et al. Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis. Am J Pathol 2005;167:365-379
7. Almqvist P, Carlsson SR. Characterization of a hydrophilic form of Thy-1 purified from human cerebrospinal fluid. J Biol Chem 1988;263:12709-12715
8. True LD, Zhang H, Ye M, et al. CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker. Mod Pathol 2010;23:1346-1356
9. Saalbach A, Wetzig T, Haustein UF, et al. Detection of human soluble Thy-1 in serum by ELISA. Fibroblasts and activated endothelial cells are a possible source of soluble Thy-1 in serum. Cell Tissue Res 1999;298:307-315
10. Zhou Y, Hagood JS, Lu B, et al. Thy-1-integrin alphav beta5 interactions inhibit lung fibroblast contraction-induced latent transforming growth factor-beta1 activation and myofibroblast differentiation. J Biol Chem 2010;285:22382-22393
11. Kukulansky T, Abramovitch S, Hollander N. Cleavage of the glycosylphosphatidylinositol anchor affects the reactivity of thy-1 with antibodies. J Immunol 1999;162:5993-5997
12. Barboni E, Rivero BP, George AJ, et al. The glycophosphatidylinositol anchor affects the conformation of Thy-1 protein. J Cell Sci 1995;108(Part 2):487-497
13. Saalbach A, Kraft R, Herrmann K, et al. The monoclonal antibody AS02 recognizes a protein on human fibroblasts being highly homologous to Thy-1. Arch Dermatol Res 1998;290:360-366
14. Bütikofer P, Malherbe T, Boschung M, et al. GPI-anchored proteins: Now you see 'em, now you don't. FASEB J 2001;15:545-548
15. Kozak M. An analysis of 50-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 1987;15:8125-8148
16. Einhauer A, Jungbauer A. The FLAG peptide, a versatile fusion tag for the purification of recombinant proteins. J Biochem Biophys Methods 2001;49:455-465
17. Hopp TP, Prickett KS, Price VL, et al. A short polypeptide marker sequence useful for recombinant protein identification and purification. Nat Biotechnol 1988;6:1204-1210
18. Devasahayam M, Catalino PD, Rudd PM, et al. The glycan processing and site occupancy of recombinant Thy-1 is markedly affected by the presence of a glycosylphosphatidylinositol anchor. Glycobiology 1999;9:1381-1387
19. Tiveron MC, Nosten-Bertrand M, Jani H, et al. The mode of anchorage to the cell surface determines both the function and the membrane location of Thy-1 glycoprotein. J Cell Sci 1994;107(Part 7):1783-1796
20. Hoessli D, Bron C, Pink Jr. T-lymphocyte differentiation is accompanied by increase in sialic acid content of Thy-1 antigen. Nature 1980;283:576-578
21. Perkins SJ, Williams AF, Rademacher TW, et al. The Thy-1 glycoprotein: A three-dimensional model. Trends Biochem Sci 1988;13:302-303
22. RobertsWL, Myher JJ, Kuksis A, et al. Lipid analysis of the glycoinositol phospholipid membrane anchor of human erythrocyte acetylcholinesterase. Palmitoylation of inositol results in resistance to phosphatidylinositolspecific phospholipase C. J Biol Chem 1988;263:18766-18775
23. Rademacher TW, Edge CJ, Dwek RA. Dropping anchor with the lipophosphoglycans. Curr Biol 1991;1:41-42
24. Leyton L, Schneider P, Labra CV, et al. Thy-1 binds to integrin b3 on astrocytes and triggers formation of focal contact sites. Curr Biol 2001;11:1028-1038
25. Avalos AM, Valdivia AD, Muñoz N, et al. Neuronal Thy-1 induces astrocyte adhesion by engaging syndecan-4 in a cooperative interaction with alphavbeta3 integrin that activates PKCalpha and RhoA. J Cell Sci 2009;122(Part 19):3462-3471
26. Mayor S, Rothberg KG, Maxfield FR. Sequestration of GPI-anchored proteins in caveolae triggered by cross-linking. Science 1994;264:1948-1951
27. Low MG, Prasad AR. A phospholipase D specific for the phosphatidylinositol anchor of cell-surface proteins is abundant in plasma. Proc Natl Acad Sci USA 1988;85:980-984
28. Davitz MA, Hom J, Schenkman S. Purification of a glycosylphosphatidylinositol-specific phospholipase D from human plasma. J Biol Chem 1989;264:13760-13764
29. Scallon BJ, Fung WJ, Tsang TC, et al. Primary structure and functional activity of a phosphatidylinositol-glycan-specific phospholipase D. Science 1991;252:446-448
30. Kondoh G, Watanabe H, Tashima Y, et al. Testicular angiotensinconverting enzyme with different glycan modification: Characterization on glycosylphosphatidylinositol-anchored protein releasing and dipeptidase activities. J Biochem 2009;145:115-121
31. Kondoh G, Tojo H, Nakatani Y, et al. Angiotensin-converting enzyme is a GPI-anchored protein releasing factor crucial for fertilization. Nat Med 2005;11:160-166
32. Mayor S. ACEing GPI release. Nat Struct Mol Biol 2005;12:107-108
33. Bergman AS, Carlsson SR. Saponin-induced release of cell-surfaceanchored Thy-1 by serum glycosylphosphatidylinositol-specific phospholipase D. Biochem J 1994;298(Part 3):661-668
34. Metz CN, Brunner G, Choi-Muira NH, et al. Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D. EMBO J 1994;13:1741-1751
35. Tetta C, Bruno S, Fonsato V, et al. The role of microvesicles in tissue repair. Organogenesis 2011;7:105-115
36. Muralidharan-Chari V, Clancy JW, Sedgwick A, et al. Microvesicles: Mediators of extracellular communication during cancer progression. J Cell Sci 2010;123:1603-1611
37. Butikofer P, Kuypers FA, Xu CM, et al. Enrichment of two glycosylphosphatidylinositol-anchored proteins, acetylcholinesterase and decay accelerating factor, in vesicles released from human red blood cells. Blood 1989;74:1481-1485
38. Kim H-S, Choi D-Y, Yun SJ, et al. Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J Proteome Res 2011;11:839-849
39. Anderson HC, Mulhall D, Garimella R. Role of extracellular membrane vesicles in the pathogenesis of various diseases, including cancer, renal diseases, atherosclerosis, and arthritis. Lab Invest 2010;90:1549-1557